South and Central America Coronary and Peripheral Stents Market Outlook (2022-2033)

The South and Central America coronary and peripheral stents market size is expected to reach US$ 601.4 million by 2033 from US$ 380.9 million in 2024. The market is estimated to record a CAGR of 5.3% from 2025 to 2033.

Executive Summary and South and Central America Coronary and Peripheral Stents Market Analysis:

The South and Central America coronary and peripheral stents market is gradually expanding, driven by rising cardiovascular disease prevalence, urbanization, and lifestyle-related risk factors such as diabetes, hypertension, and obesity. Major urban hospitals are increasingly adopting minimally invasive interventions, with coronary stents forming the bulk of usage, while peripheral stents are gaining relevance for complex vascular and diabetic limb cases. Market growth is restrained by uneven access to catheterization laboratories in rural areas, limited procedural infrastructure in smaller cities, and dependence on imported stent technologies. Price sensitivity in public hospitals and reimbursement variability across countries also influence device adoption. Despite these challenges, regional investments in healthcare infrastructure, expansion of high-capacity cardiac centers, and targeted physician training programs are supporting the gradual uptake of interventional procedures. Public and private partnerships are enhancing procedural efficiency, making the market more accessible in key urban hubs across South and Central America.

South and Central America Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.

South and Central America Coronary and Peripheral Stents Market Outlook

The South and Central America coronary and peripheral stents market is concentrated in large tertiary-care hospitals and referral centers, where coronary stenting dominates procedural volumes. Peripheral stents are increasingly applied in patients with advanced vascular complications, particularly associated with diabetes and peripheral artery disease. A key driver is the expansion of specialized cardiovascular programs and hospital networks in urban areas, which has improved patient access to interventional procedures. Increasing awareness among clinicians and patients about the benefits of minimally invasive interventions over surgical alternatives supports broader adoption. Investments in diagnostic facilities, catheterization laboratories, and interventional cardiology training have enhanced procedural capacity and efficiency. As patient referrals become more streamlined and procedural confidence grows among clinicians, the adoption of both coronary and peripheral stents is expected to continue rising steadily in the region’s primary healthcare hubs.

South and Central America Coronary and Peripheral Stents Market Country Insights

Based on country, the South and Central America coronary and peripheral stents market is further segmented into Brazil, Argentina, Chile, Colombia, Peru and Rest of South and Central America. Brazil held the largest share in 2024.

Brazil dominates the South and Central America coronary and peripheral stents market due to its large patient population, advanced private healthcare network, and growing interventional cardiology infrastructure. Major urban centers host high-volume cardiac hospitals equipped with modern catheterization laboratories, supporting widespread adoption of coronary stents. Peripheral stenting is expanding, particularly for diabetic and vascular disease patients requiring complex interventions. Government healthcare initiatives and private insurance coverage facilitate access to interventional procedures, while established distributor networks ensure consistent device availability. Physician training, standardized treatment protocols, and hospital modernization contribute to high procedural quality and efficiency. Although access remains uneven in remote regions, Brazil’s scale, healthcare infrastructure, and clinical expertise firmly establish it as the leading stents market in South and Central America.

South and Central America Coronary and Peripheral Stents Market Company Profiles

Medtronic, Johnson & Johnson, B. Braun SE, Lepu Medical, Intuitive Surgical Inc, Hologic Inc, Meril Life Sciences Pvt Ltd, Purple Surgical, Bluesail Medical, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

South and Central America Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

South and Central America Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• American Society for Metabolic and Bariatric Surgery
• International Federation for the Surgery of Obesity
• British Obesity & Metabolic Specialist Society
• Company website
• Company annual reports
• Company investor presentations